Literature DB >> 15988928

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

Hye Young Park1, Kayoung Yi, Ha Kyoung Kim.   

Abstract

PURPOSE: This study investigated firstly the change of intraocular pressure (IOP) after injection of intravitreal triamcinolone acetonide (IVTA) for the treatment of macular edema and secondly the factors that influence these changes.
METHODS: A prospective, non-comparative study was performed in 60 patients at Kangnam Sacred Heart Hospital from October 2003 to September 2004. All the patients received 4-mg IVTA injection.
RESULTS: Mean IOP was elevated from the day after injection and peaked at 20.5 mmHg after 2 months (p=0.000). Twenty-six eyes (43.3%) showed significant IOP elevation. IOP was not controlled despite full glaucoma medication in 7 (11.7%) eyes. Two eyes underwent filtering surgery. Younger age was a statistically significant predictive factor for IOP elevation (p=0.009).
CONCLUSIONS: In this study, patients who needed filtering surgery developed an IOP spike within one week after the injection. Therefore, clinicians should consider checking IOP at the end of the first week. Furthermore, greater cautions is mandatory with relatively younger patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988928     DOI: 10.3341/kjo.2005.19.2.122

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  11 in total

1.  The problem of pressure elevation associated with intravitreal triamcinolone.

Authors:  M D Conway
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

2.  Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections.

Authors:  A M Tammewar; L Cheng; O R Kayikcioglu; I A Falkenstein; I Kozak; M H Goldbaum; W R Freeman
Journal:  Br J Ophthalmol       Date:  2008-04-17       Impact factor: 4.638

3.  Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.

Authors:  Cansu Yuksel-Elgin; Ceyhun Elgin
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

4.  Intraocular pressure alterations following intravitreal triamcinolone acetonide.

Authors:  D J Rhee; R E Peck; J Belmont; A Martidis; M Liu; J Chang; J Fontanarosa; M R Moster
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

5.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.

Authors:  Zhenyu Dong; Kenichi Namba; Nobuyoshi Kitaichi; Chiho Goda; Mizuki Kitamura; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

6.  Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

Authors:  M Selim Kocabora; Cemil Yilmazli; Muhittin Taskapili; Gokhan Gulkilik; Sahan Durmaz
Journal:  Clin Ophthalmol       Date:  2008-03

7.  Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.

Authors:  Young Jae Choi; In Kyung Oh; Jae Ryung Oh; Kuhl Huh
Journal:  Korean J Ophthalmol       Date:  2006-12

8.  Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery.

Authors:  Saeed Shokoohi-Rad; Ramin Daneshvar; Mahsa Jafarian-Shahri; Parisa Rajaee
Journal:  J Curr Ophthalmol       Date:  2017-12-07

9.  Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.

Authors:  Yuki Maeda; Hiroto Ishikawa; Hiroki Nishikawa; Miho Shimizu; Takamasa Kinoshita; Rie Ogihara; Shigehiko Kitano; Chihiro Yamanaka; Yoshinori Mitamura; Masahiko Sugimoto; Mineo Kondo; Yoshihiro Takamura; Nahoko Ogata; Tomohiro Ikeda; Fumi Gomi
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

Review 10.  Intravitreal steroids for the treatment of retinal diseases.

Authors:  Valentina Sarao; Daniele Veritti; Francesco Boscia; Paolo Lanzetta
Journal:  ScientificWorldJournal       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.